Clinical Updates
Drug approvals, guideline changes, and treatment advances
Blood test with circular RNA markers predicts Alzheimer’s disease years before symptoms emerge
A blood test measuring 34 circular RNA markers predicts Alzheimer's disease progression with 92% accuracy, outperforming current protein biomarkers and…
Editor's Top Picks
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Submit Your Paper →
More form Clinical Updates
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals
BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition, with diagnostic delays…
Health Expert Addresses Rising Peptide Use, Colorectal Cancer Screening Gaps, and Ebola Preparedness
Dr. Céline Gounder discusses growing concerns about unregulated peptide use, persistent gaps in cancer screening…
Multi-arm platform trials could revolutionize neurological disease research
Platform trials could test 15-20 neurological treatments per decade compared to 3-5 using traditional methods.…
Multiple Myeloma Treatment Paradigm Shift: New Guidelines Redefine Early Relapse
New England Journal of Medicine editorial calls for fundamental changes to multiple myeloma early relapse…
New International Guidelines Standardize Ultrasound Monitoring for Post-Surgery Crohn’s Disease Patients
International experts publish new guidelines to standardize intestinal ultrasound monitoring for Crohn's disease patients after…